The rapid detection of respiratory pathogens in critically ill children.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
10 01 2023
Historique:
received: 01 11 2022
accepted: 06 01 2023
entrez: 10 1 2023
pubmed: 11 1 2023
medline: 13 1 2023
Statut: epublish

Résumé

Respiratory infections are the most common reason for admission to paediatric intensive care units (PICU). Most patients with lower respiratory tract infection (LRTI) receive broad-spectrum antimicrobials, despite low rates of bacterial culture confirmation. Here, we evaluated a molecular diagnostic test for LRTI to inform the better use of antimicrobials. The Rapid Assay for Sick Children with Acute Lung infection Study was a single-centre, prospective, observational cohort study of mechanically ventilated children (> 37/40 weeks corrected gestation to 18 years) with suspected community acquired or ventilator-associated LRTI. We evaluated the use of a 52-pathogen custom TaqMan Array Card (TAC) to identify pathogens in non-bronchoscopic bronchoalveolar lavage (mini-BAL) samples. TAC results were compared to routine microbiology testing. Primary study outcomes were sensitivity and specificity of TAC, and time to result. We enrolled 100 patients, all of whom were tested with TAC and 91 of whom had matching culture samples. TAC had a sensitivity of 89.5% (95% confidence interval (CI TAC is a reliable and rapid adjunct diagnostic approach for LRTI in critically ill children, with the potential to aid early rationalisation of antimicrobial therapy.

Identifiants

pubmed: 36627688
doi: 10.1186/s13054-023-04303-1
pii: 10.1186/s13054-023-04303-1
pmc: PMC9831374
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11

Subventions

Organisme : Medical Research Council
ID : MR/V006118/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 205214/Z/16/Z
Pays : United Kingdom
Organisme : Addenbrooke's Charitable Trust, Cambridge University Hospitals
ID : 900240
Organisme : Medical Research Council
ID : MR/N029399/1
Pays : United Kingdom
Organisme : Gates Cambridge Trust
ID : OPP1144

Informations de copyright

© 2023. The Author(s).

Références

Thorax. 2022 Dec;77(12):1220-1228
pubmed: 35027473
Pediatr Crit Care Med. 2013 Sep;14(7):673-81
pubmed: 23863821
Diagn Microbiol Infect Dis. 2021 Nov;101(3):115476
pubmed: 34303085
Front Cell Infect Microbiol. 2021 Sep 09;11:694756
pubmed: 34568089
Front Med (Lausanne). 2022 Jul 15;9:952636
pubmed: 35911412
Wellcome Open Res. 2021 Oct 11;6:256
pubmed: 36337362
BMJ Open. 2021 Nov 29;11(11):e056197
pubmed: 34845080
Nat Biotechnol. 2019 Jul;37(7):783-792
pubmed: 31235920
J Clin Microbiol. 2020 Jun 24;58(7):
pubmed: 32321782
Am J Respir Crit Care Med. 2019 Oct 1;200(7):828-836
pubmed: 31034248
Clin Microbiol Infect. 2018 Oct;24(10):1055-1063
pubmed: 29208560
BMJ Qual Saf. 2022 Mar;31(3):199-210
pubmed: 34099497
Infect Control Hosp Epidemiol. 2022 Nov;43(11):1553-1557
pubmed: 34812135
Antimicrob Resist Infect Control. 2021 Jun 29;10(1):95
pubmed: 34187563
Lancet Respir Med. 2022 Sep;10(9):877-887
pubmed: 35617987
J Clin Microbiol. 2020 Jun 24;58(7):
pubmed: 32350045
J Clin Virol. 2013 Jul;57(3):254-60
pubmed: 23608639
BMC Infect Dis. 2019 Nov 6;19(1):938
pubmed: 31694565
Trials. 2021 Oct 7;22(1):680
pubmed: 34620213
Lancet Microbe. 2021 Jan;2(1):e13-e22
pubmed: 33521734
Crit Care. 2021 Jan 11;25(1):25
pubmed: 33430915
Open Forum Infect Dis. 2017 Feb 10;4(1):ofx014
pubmed: 28480285
PLoS One. 2020 Jun 4;15(6):e0232610
pubmed: 32497137
Infect Control Hosp Epidemiol. 2017 Aug;38(8):993-997
pubmed: 28560946
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
J Microbiol Immunol Infect. 2019 Dec;52(6):920-928
pubmed: 31806539
Wellcome Open Res. 2021 May 18;6:119
pubmed: 35299710
J Clin Microbiol. 2020 Jun 24;58(7):
pubmed: 32350043
BMC Infect Dis. 2020 Nov 10;20(1):820
pubmed: 33172401
Eur J Pediatr. 2009 Dec;168(12):1429-36
pubmed: 19238436
J Infect Dis. 2020 Jan 14;221(3):379-388
pubmed: 31541573
J Clin Microbiol. 2011 Jun;49(6):2175-82
pubmed: 21471348
Microbiol Spectr. 2022 Oct 26;10(5):e0148822
pubmed: 36169415

Auteurs

John A Clark (JA)

Department of Paediatrics, Addenbrooke's Hospital, University of Cambridge, Level 8, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. jac302@cam.ac.uk.
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. jac302@cam.ac.uk.

Andrew Conway Morris (A)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, UK.
Division of Immunology, Department of Pathology, University of Cambridge, Cambridge, UK.

Martin D Curran (MD)

Clinical Microbiology and Public Health Laboratory, United Kingdom Health Security Agency, Cambridge, UK.

Deborah White (D)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Esther Daubney (E)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Iain R L Kean (IRL)

Department of Paediatrics, Addenbrooke's Hospital, University of Cambridge, Level 8, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.

Vilas Navapurkar (V)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Josefin Bartholdson Scott (J)

Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.

Mailis Maes (M)

Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.

Rachel Bousfield (R)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Clinical Microbiology and Public Health Laboratory, United Kingdom Health Security Agency, Cambridge, UK.

M Estée Török (ME)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Division of Infectious Diseases, Department of Medicine, University of Cambridge, Cambridge, UK.

David Inwald (D)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Zhenguang Zhang (Z)

Department of Paediatrics, Addenbrooke's Hospital, University of Cambridge, Level 8, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.

Shruti Agrawal (S)

Department of Paediatrics, Addenbrooke's Hospital, University of Cambridge, Level 8, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Constantinos Kanaris (C)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Blizard Institute, Queen Mary University of London, London, UK.

Fahad Khokhar (F)

Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.

Theodore Gouliouris (T)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Clinical Microbiology and Public Health Laboratory, United Kingdom Health Security Agency, Cambridge, UK.

Stephen Baker (S)

Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.

Nazima Pathan (N)

Department of Paediatrics, Addenbrooke's Hospital, University of Cambridge, Level 8, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH